ClinicalTrialsFinder

Lymphoma, Extranodal NK-T-Cell Clinical Trials in Guangzhou

1 recruitingGuangzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell
International Extranodal Lymphoma Study Group (IELSG)30 enrolled2 locationsNCT04417166